epoc studies: preoperative cetuximab in kras wild-type colorectal cancer
Published 10 years ago • 1.1K plays • Length 5:27Download video MP4
Download video MP3
Similar videos
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
0:11
folfox and cetuximab kras wild type colon cancer
-
2:20
what is the best treatment for ras wild-type metastatic colorectal cancer?
-
8:41
calgb 80405 trial results in metastatic colorectal cancer
-
2:45
1l folfoxiri plus cetuximab or bevacizumab for ras wild-type mcrc
-
0:57
dr. peeters discusses the efficacy and safety of panitumumab versus cetuximab in colorectal cancer
-
1:50
dr. benson on sequencing strategies with cetuximab in crc
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
3:59
asco 2013: cetuximab superior to bevacizumab for advanced colorectal cancer
-
2:18
what are the implications of kras mutations in colon cancer?
-
2:10
anti-egfr therapy for ras wild-type left-sided colorectal cancer
-
7:20
treating metastatic colorectal cancer: case study review
-
5:52
expanded ras mutation testing in metastatic colorectal cancer
-
4:20
frontline treatment for kras wild-type mcrc
-
1:08
dr. weinberg on the role of cetuximab in metastatic crc
-
6:21
braf and ras mutation status in colorectal cancer
-
8:37
cetuximab with xelox or xeliri is tolerable and effective in ras wild-type mcrc
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer